Toggle light / dark theme

NASA is focusing increasingly on interplanetary missions to faraway places like Mars, and such highly ambitious voyages will require robotic equipment to assist astronauts with a range of tasks.

With that in mind, a team of researchers at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland is developing a remarkable robot called Mori3 that’s capable of changing its size, shape, and function, morphing from 2D triangles into almost any 3D object. You can see it in action in the video above.

Researchers at the RIKEN Center for Brain Science (CBS) in Japan have discovered a set of related mutations that lead to intracranial aneurysms—weakened blood vessels in the brain that can burst at any time. The mutations all appear to act on the same biological signaling pathway, and the researchers report the first ever pharmaceutical treatment in a mouse model, which works by blocking this signal. The study was published in Science Translational Medicine.

About 5% of the population have unruptured intracranial aneurysms in blood vessels on the surface of the brain. Despite being ballooned arteries with weakened walls, intracranial aneurysms often go undetected—until a rupture leads to deadly bleeding around the brain.

Even when they are detected in advance, the only currently available treatment options involve surgery, which has its own set of risks, especially if the aneurysm is in a sensitive location. Finding other, non-surgical options is thus a high priority, and research into the origin of intracranial aneurysms has led the RIKEN CBS team to one such potential treatment.

In large organizations, complexity can lead to less efficient processes and projects that aren’t aligned with business strategy. A modern business management tool can help enterprise architects, leaders and relevant stakeholders gain control and ensure efforts are prioritized and anchored correctly. Cutting projects that aren’t business critical or growth enablers might be the right thing to do, even if the ideas they’re based upon are great. As a result, freeing up time and saving costs can empower the organization to onboard new projects faster and leverage AI and its possibilities before its competitors do.

How can technology leaders best leverage AI to benefit their companies and their customers? Here at Ardoq, we’ve focused on a few key areas that all technology leaders could benefit from.

1. Allow for and encourage continuous innovation. This includes always evaluating the type of technology your business is based on. If your organization is already based on modern technology and has a data-driven approach, you can be more agile when it comes to adopting and leveraging AI. AI will create disruptions as well as open up new opportunities. This is an opportunity for leaders to create momentum and embrace an iterative approach that will help their people feel that they’re staying ahead of the curve.

A great video on the history of electric cars. I love the AI voice. Also notice Tesla was incorporated in July 2003 by Martin Eberhard and Marc Tarpenning as Tesla Motors. The company’s name is a tribute to inventor and electrical engineer. Elon Musk was an investor.


While electric vehicles (EV) have only recently begun to challenge the internal combustion engine (ICE) for the future of our roads, EVs have been around for over a century. The long history of EVs has been one of many twists and turns.

In this video, you can get a clear idea about the birth, the downfall, rebirth and the rise of electric cars around the world.

It took Da Vinci 16 years to paint the Mona Lisa. Some say he needed 12 years just to paint her lips.

There is no truth to the rumors that slow Internet was the cause.

But Da Vinci, a polymath who dabbled in botany, engineering, science, sculpture, and geology as well as painting, surely would have appreciated a new text-to-image generative vision transformer developed by Google Research.

Mitochondria that power cellular activity fragment and change shape in breast cancer cells that migrate to the brain, an adaptation that appears necessary for the cells to survive, UT Southwestern Medical Center researchers report in a new study. The findings, published in Nature Cancer, could lead to new ways to prevent brain metastases, or the spread of cells from primary tumors to the brain.

“Through mitochondrial plasticity, these cancer cells undergo metabolic reprogramming that aids their survival in the brain niche that otherwise would not be available to them. Exploiting this vulnerability could offer a way to prevent brain metastases,” said study leader Srinivas Malladi, Ph.D., Assistant Professor of Pathology at UT Southwestern and a member of the Harold C. Simmons Comprehensive Cancer Center.

Metastatic cancer, which is treated as stage IV cancer, is responsible for the majority of cancer deaths.

In short, data-driven solutions themselves are only part of the overall approach. It is the effective integration of this fast-evolving technology into existing workflows and processes that leads to successful business outcomes.

The first step to integrating AI is identifying places and processes where it can help increase efficiency or accuracy. Businesses should step back and identify their pain points, creating a list of processes that are slow, tedious, cumbersome or suffering from a lack of staff. They should also analyze where additional data or information could help make better decisions.

In the pharma industry, data-driven AI solutions have been widely adopted in sales and marketing processes. For example, by analyzing patient and physician data, electronic medical records and demographic information, AI algorithms can identify trends, patterns and insights that help sales representatives tailor their messaging and presentations to specific HCPs.